Bloomberg Talks cover image

Eli Lilly CEO Dave Ricks Talks Weight Loss Drugs Success

Bloomberg Talks

CHAPTER

Innovations in Weight Loss Medications

This chapter explores the unexpected benefits of Exenetide, a diabetes drug that aids in weight loss, and compares it with terzepatide in terms of mechanisms and effectiveness. It highlights the alarming rise in obesity rates, the healthcare challenges surrounding weight loss medications, and the significant role of insurance in treatment accessibility. Additionally, the discussion addresses the threats posed by counterfeit drugs, ongoing research for oral alternatives, and the complexities of maintaining weight loss post-medication.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner